Urgent treatment of patients with metastatic melanoma using braf inhibitors in the absence of braf mutation status

ISSN： 0923-7534

Source： Annals of Oncology, Vol.24, Iss.6, 2013-06, pp. : 1712-1713

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Progression patterns under BRAF inhibitor treatment and treatment beyond progression in patients with metastatic melanoma

Cancer Medicine, Vol. 7, Iss. 1, 2018-01 ,pp. : 95-104

John Wiley & Sons Inc

Access to resources Recommend Favorite

From targeted monotherapy to combined BRAF–MEK inhibitors and integrated genome analysis for melanoma treatment

By Roukos Dimitrios H Papaloukas Costas Tzaphlidou Margaret

Future Oncology, Vol. 9, Iss. 1, 2013-01 ,pp. : 5-8

Future Medicine

Access to resources Recommend Favorite

Development of a novel chemical class of BRAF inhibitors offers new hope for melanoma treatment

By Smalley Keiran SM Flaherty Keith T

Future Oncology, Vol. 5, Iss. 6, 2009-08 ,pp. : 775-778

Future Medicine

Access to resources Recommend Favorite

Rationally Designed Drug Development Beyond BRAF Inhibition in Metastatic Cutaneous Melanoma

By Lemech C.R. Arkenau H.-T.

Cancer Hallmarks, Vol. 1, Iss. 1, 2013-04 ,pp. : 37-49

American Scientific Publishers

Access to resources Recommend Favorite

The role of B-RAF in melanoma

By Gray-Schopfer Vanessa

Cancer and Metastasis Reviews, Vol. 24, Iss. 1, 2005-01 ,pp. : 165-183

Springer Publishing Company

Access to resources Recommend Favorite